View All Documents & Correspondence
A Composition Comprising Phycocyanin And A Salt Of Magnesium To Address Metabolic Acidosis
Abstract: The present disclosure relates to a composition comprising phycocyanin and at least one salt of magnesium which at specific ratios is able to reduce osteoclast activity and reduce the ill-effects of metabolic acidosis. Also provided are methods for preparation and use of said composition.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. DSOUZA, Avin
2. GOPAL, Ganesh
Specification
Claims:1. A composition comprising:
(a) phycocyanin; and
(b) at least one salt of magnesium,
wherein phycocyanin to the at least one salt of magnesium w/w ratio in said composition is in the range of 1:2- 1:50.
2. The composition as claimed in claim 1, wherein phycocyanin to the at least one salt of magnesium w/w ratio in said composition is in the range of 1:2- 1:20.
3. The composition as claimed in claim 1, wherein phycocyanin to the at least one salt of magnesium w/w ratio in said composition is in the range of 1:2.50- 1:15.
4. The composition as claimed in claim 1, wherein the at least one salt of magnesium is selected from the group consisting of magnesium chloride, magnesium sulfate, magnesium bromide, magnesium fluoride, magnesium iodide, magnesium phosphate, and combinations thereof.
5. The composition as claimed in claim 1, wherein the at least one salt of magnesium is magnesium chloride.
6. The composition as claimed in claim 1, further comprising:
(a) at least one carrier;
(b) at least one diluent; and
(c) at least one excipient.
7. A method for preparing a composition as claimed in claim 1, comprising:
(a) obtaining phycocyanin;
(b) obtaining at least one salt of magnesium; and
(c) contacting phycocyanin and the at least one salt of magnesium to obtain said composition.
8. A method for preparing a composition as claimed in any of the claims 1-6, comprising:
(a) obtaining phycocyanin;
(b) obtaining at least one salt of magnesium;
(c) obtaining the at least one carrier;
(d) obtaining the at least one diluent;
(e) obtaining the at least one excipient; and
(f) contacting phycocyanin, the at least one salt of magnesium, the at least one carrier, the at least one diluent, and the at least one excipient to obtain said composition.
9. The composition as claimed in any of the claims 1-6, wherein said composition reduces osteoclast activity.
10. The composition as claimed in any of the claims 1-6, wherein said composition inhibits acidosis.
, Description:AS ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [26-05-2017(online)].pdf | 2017-05-26 |
| 2 | Form 3 [26-05-2017(online)].pdf | 2017-05-26 |
| 3 | Drawing [26-05-2017(online)].pdf | 2017-05-26 |
| 4 | Description(Complete) [26-05-2017(online)].pdf_53.pdf | 2017-05-26 |
| 5 | Description(Complete) [26-05-2017(online)].pdf | 2017-05-26 |
| 6 | 201741018653-Proof of Right (MANDATORY) [20-07-2017(online)].pdf | 2017-07-20 |
| 7 | 201741018653-FORM-26 [20-07-2017(online)].pdf | 2017-07-20 |
| 8 | Correspondence by Agent_Power Of Authorisation_24-07-2017.pdf | 2017-07-24 |
| 9 | IMPORTANT LETTER FROM NBA.pdf | 2019-03-21 |
| 10 | 201741018653-FORM 18 [25-03-2021(online)].pdf | 2021-03-25 |
| 11 | 201741018653-FER.pdf | 2023-03-06 |
| 12 | 201741018653-OTHERS [31-08-2023(online)].pdf | 2023-08-31 |
| 13 | 201741018653-FER_SER_REPLY [31-08-2023(online)].pdf | 2023-08-31 |
| 14 | 201741018653-US(14)-HearingNotice-(HearingDate-18-03-2024).pdf | 2024-02-29 |
| 15 | 201741018653-FORM-26 [15-03-2024(online)].pdf | 2024-03-15 |
| 16 | 201741018653-Correspondence to notify the Controller [15-03-2024(online)].pdf | 2024-03-15 |
| 17 | 201741018653-Written submissions and relevant documents [01-04-2024(online)].pdf | 2024-04-01 |
| 18 | 201741018653-PatentCertificate24-04-2024.pdf | 2024-04-24 |
| 19 | 201741018653-IntimationOfGrant24-04-2024.pdf | 2024-04-24 |
Search Strategy
| 1 | SearchHistoryE_02-03-2023.pdf |